A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due ...

A new discovery could pave the way for more effective cancer treatment by helping certain drugs work better inside the body.

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor ...

There are two main types of lung cancer: non-small cell lung cancer and small cell lung cancer. People with non-small cell lung cancer tend to have a better prognosis than people with small cell lung ...

It has been one year since King Charles‘s cancer diagnosis on 5 February, 2024. Doctors said they were ‘very encouraged’ by his progress after finding that Charles had cancer and remained ...

That's because lung cancer becomes more difficult to treat as it progresses. According to the American Cancer Society, those with stage 4 non-small cell lung cancer (NSCLC) diagnosed between 2012 and ...

With the latest overall survival win in hand, J&J believes it holds the key to ending Tagrisso’s long reign in first-line EGFR lung cancer ... because the small number of total deaths means ...

Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States ...

Small-cell lung cancer (SCLC) is the most aggressive type of lung cancer. Each year in the U.S., about 30,000 to 35,000 people are diagnosed with it. For most, it has already spread to distant ...

Century Therapeutics has joined the onslaught of cell therapy biotechs taking hits, discontinuing a phase 1 cancer study to turn its focus toward autoimmune diseases. The move isn’t shocking ...

"Part of their genome is encoded in their own small genome but also essential parts are encoded in the nucleus" of the surrounding cell, says Coale. But in this case, the process led to the ...